J, S., WJ, C., A, W., & M, G. (2020). Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression. Dove Medical Press.
Chicago Style (17th ed.) CitationJ, Szarmach, Cubała WJ, Włodarczyk A, and Gałuszko-Węgielnik M. Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression. Dove Medical Press, 2020.
MLA (8th ed.) CitationJ, Szarmach, et al. Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.